REFERENCES
- Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405‒412. doi:10.2147/opth.s4935.
- Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264‒1268. doi:10.1001/archopht.118.9.1264.
- Lemp MA. Report of the National Eye Institute/Industry Workshop on clinical trials in dry eyes. CLAO J. 1995;21(4):221‒232.
- The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):75‒92.
- Gipson IK. The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007;48(10):4391‒4398. doi:10.1167/iovs.07-0770.
- Thulasi P, Djalilian AR. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology. 2017;124:S27‒S33. doi:10.1016/j.ophtha.2017.07.022.
- Rolando M, Refojo MF, Kenyon KR. Tear water evaporation and eye surface diseases. Ophthalmologica. 1985;190(3):147‒149. doi:10.1159/000309511.
- Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. 2001;45(Suppl 2):S203‒210. doi:10.1016/S0039-6257(00)00203-4.
- Baudouin C, Aragona P, Van Setten G, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168‒1176. doi:10.1136/bjophthalmol-2013-304619.
- Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;11(4):246‒258. doi:10.1016/j.jtos.2013.07.003.
- Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4):802‒812. doi:10.1016/j.jtos.2017.08.003.
- Nepp J, Wirth M. Fluctuations of corneal sensitivity in dry eye syndromes – a longitudinal pilot study. Cornea. 2015;34:1221‒1226. doi:10.1097/ICO.0000000000000566.
- Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428‒435. doi:10.1038/nature07201.
- Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res. 2012;31:271‒285. doi:10.1016/j.preteyeres.2012.02.003.
- Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface dysfunctions. Br J Ophthalmol. 2013;97(8):955‒960. doi:10.1136/bjophthalmol-2012-302568.